Beutel, Goodman & Co’s Colgate-Palmolive CL Stock Holding History

Beutel, Goodman & Co’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$93K	Sell	1,100 -300	-21%	-$26.7K	﹤0.01%	131
2025 Q4	$110K	Hold	1,400	–	–	﹤0.01%	129
2025 Q3	$111K	Hold	1,400	–	–	﹤0.01%	127
2025 Q2	$127K	Sell	1,400 -900	-39%	-$82.2K	﹤0.01%	124
2025 Q1	$215K	Buy	+2,300	New	+$206K	﹤0.01%	127
2018 Q2	–	Sell	-35,159	Closed	-$1.95M	–	64
2018 Q1	$1.95M	Sell	35,159 -9,855	-22%	-$709K	0.01%	57
2017 Q4	$2.71M	Buy	+45,014	New	+$3.29M	0.02%	61

Other funds holding CL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Beutel, Goodman & Co's CL Position: Q1 2026 in Review

Beutel, Goodman & Co reduced its Colgate-Palmolive (CL) stake by 21% in Q1 2026, selling an estimated $26.7K and leaving 1,100 shares worth $93K. The position accounts for ﹤0.01% of the portfolio, ranked #131.

Beutel, Goodman & Co first reported a position in CL in Q4 2017 and has held it in 7 quarters since. The position peaked at $2.71M in Q4 2017. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

Beutel, Goodman & Co held 1,100 shares of Colgate-Palmolive worth $93K as of Q1 2026.
Beutel, Goodman & Co sold 300 Colgate-Palmolive shares in Q1 2026, an estimated $26.7K.
Colgate-Palmolive made up ﹤0.01% of Beutel, Goodman & Co's portfolio in Q1 2026, its #131 holding.
Beutel, Goodman & Co first reported a position in Colgate-Palmolive in Q4 2017 and has held it in 7 quarters since.
Beutel, Goodman & Co's Colgate-Palmolive position peaked at $2.71M in Q4 2017.
1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Beutel, Goodman & Co's 13F filing for Q1 2026, filed 15 May 2026.